MedTrace Logo

Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis

NCT01799863 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-04-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the evolution of the symptoms of acute viral conjunctivitis using preservative free ketorolac trometamol 0.45% associated with carboxymethylcellulose compared with isolated use of preservative-free artificial tears.

Conditions

  • Conjunctivitis, Viral

Interventions

DRUG

Ketorolac trometamol 0.45% with carboxymethylcellulose

DRUG

Preservative free artificial tear

Sponsors & Collaborators

  • Fundação Altino Ventura

    lead OTHER

Principal Investigators

  • Adriana Falcão, MD · Fundação Altino Ventura

  • Lucio Maranhão, MD · Fundação Altino Ventura

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799863 on ClinicalTrials.gov